logo
Introduction
Plasma Clozapine Concentrations as a Predictor of Clinical Response: A Follow-Up Study
Plasma Clozapine Concentrations Predict Clinical Response in Treatment-Resistant Schizophrenia
Plasma Clozapine Levels and Clinical Response for Treatment-Refractory Schizophrenic Patients
Predictors of Response to Clozapine
Clozapine and Weight Gain
Clozapine, Negative Symptoms, and Extrapyramidal Side Effects
Treatment of Clozapine-Induced Agranulocytosis With Recombinant Granulocyte Colony-Stimulating Factor
Clinical Effects of Clozapine in Chronic Schizophrenia: Response to Treatment and Predictors of Outcome
Reduction of Suicidality During Clozapine Treatment of Neuroleptic-Resistant Schizophrenia: Impact on Risk-Benefit Assessment
Allelic Variation in the D4 Dopamine Receptor (DRD4) Gene Does Not Predict Response to Clozapine
Risperidone in the Treatment of Schizophrenia
Randomized, Double-Blind, Controlled Trial of Risperidone Versus Clozapine in Patients With Chronic Schizophrenia
Effects of Risperidone in Tardive Dyskinesia: An Analysis of the Canadian Multicenter Risperidone Study
Risk Factors for Spontaneous Dyskinesia in Schizophrenia
Coadministration of Fluvoxamine Increases Serum Concentrations of Haloperidol
Neurological Soft Signs in Neuroleptic-Naive and Neuroleptic-Treated Schizophrenic Patients and in Normal Comparison Subjects
Neuropsychological Impairments in Deficit vs Nondeficit Forms of Schizophrenia
Ten-Year Outcome of Tardive Dyskinesia
Clozapine Therapy in Refractory Affective Disorders: Polarity Predicts Response in Long-Term Follow-up
Pharmacotherapy of Impaired Affect in Recovering Schizophrenic Patients
Treatment of Negative Symptoms in Schizophrenia With Amisulpride
Antidepressant-Associated Mania: A Controlled Comparison With Spontaneous Mania
Use of ECT in the United States in 1975, 1980, and 1986
Effects of Low-Dose TRH on Cognitive Deficits in the ECT Postictal State
A Canadian Multicentre Placebo-Controlled Study of a Fixed Dose of Brofaromine, a Reversible Selective MAO-A Inhibitor, in the Treatment of Major Depression
Treatment Response of Depressed Outpatients Unresponsive to Both a Tricyclic and a Monoamine Oxidase Inhibitor Antidepressant
Dexamethasone for the Treatment of Depression: A Randomized, Placebo-Controlled, Double-Blind Trial
Lithium and Tricyclic Augmentation of Fluoxetine Treatment for Resistant Major Depression: A Double-Blind, Controlled Study
Switch in Treatment From Tricyclic Antidepressants to Moclobemide: A New Generation Monoamine Oxidase Inhibitor
Mechanism of Inositol Monophosphatase, the Putative Target of Lithium Therapy
Long-Term Safety and Clinical Acceptability of Venlafaxine and Imipramine in Outpatients With Major Depression
Venlafaxine for Treatment-Resistant Unipolar Depression
Dose-Response Studies With Protirelin
Is Clozapine a Mood Stabilizer?
Blood Dyscrasias With Carbamazepine and Valproate: A Pharmacoepidemiological Study of 2,228 Patients at Risk
Comparative Efficacy of Selective Serotonin Reuptake Inhibitors and Tricyclics in the Treatment of Melancholia
High-Dose Selegiline in Treatment-Resistant Older Depressive Patients
Orally Administered Progesterone Enhances Sensitivity to Triazolam in Postmenopausal Women
Phobic Symptoms as Predictors of Nonresponse to Drug Therapy in Panic Disorder Patients (a Preliminary Report)
The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic Disorder
A Double-Blind, Placebo-Controlled, Multicenter Study With Alprazolam and Extended-Release Alprazolam in the Treatment of Panic Disorder
A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-Compulsive Disorder
Double-Blind Parallel Comparison of Three Dosages of Sertraline and Placebo in Outpatients With Obsessive-Compulsive Disorder
Efficacy Trial of the 5-HT2 Antagonist MDL 11,939 in Patients With Generalized Anxiety Disorder
The Effect of Tacrine and Lecithin in Alzheimer's Disease: A Population Pharmacodynamic Analysis of Five Clinical Trials
Buprenorphine Versus Methadone in the Treatment of Opioid-Dependent Cocaine Users
The Relationship of Postoperative Delirium With Psychoactive Medications
Effective Treatment of Poststroke Depression With the Selective Serotonin Reuptake Inhibitor Citalopram
A Systematic Assessment of Tricyclic Antidepressants in the Treatment of Adult Attention-Deficit Hyperactivity Disorder
Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients With Schizophrenia
What Price Depression?: The Cost of Depression and the Cost-Effectiveness of Pharmacological Treatment